Ceruletide suppresses endogenous dopamine release via vagal afferent system, studied by in vivo intracerebral dialysis

[1]  U. Ungerstedt,et al.  Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbens using intracerebral dialysis in the anaesthetized rat , 1987, Neurochemistry International.

[2]  P. McHugh,et al.  Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches , 1987, Brain Research.

[3]  C. Jacquot,et al.  Cholecystokinin and bombesin in vagotomized or intact lean and obese rats: Effects on neurotransmitters in brain , 1987, Neuropharmacology.

[4]  J. Morley,et al.  Modulation of memory processing by cholecystokinin: dependence on the vagus nerve. , 1987, Science.

[5]  Y. Hagino,et al.  Bilateral subdiaphragmatic vagotomy does not prevent the behavioral effects of systematically administered ceruletide in mice , 1987, Neuropeptides.

[6]  A. Crossman,et al.  Primate models of dyskinesia: The experimental approach to the study of basal ganglia-related involuntary movement disorders , 1987, Neuroscience.

[7]  T. Moroji,et al.  A comparative study on characterization and distribution of cholecystokinin binding sites among the rat, mouse and guinea pig brain , 1986, Brain Research.

[8]  J. Hutchison,et al.  Release of endogenous dopamine and cholecystokinin from rat striatal slices: effects of amphetamine and dopamine antagonists , 1986, Brain Research.

[9]  G. Zetler.  Neuropharmacological Profile of Cholecystokinin‐like Peptides , 1985, Annals of the New York Academy of Sciences.

[10]  M. Palkovits,et al.  Cholecystokinin-induced excitation in the substantia nigra: evidence for peripheral and central components , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  K. Inouye,et al.  Effects of caerulein-related peptides on cholecystokinin receptor bindings in brain and pancreas. , 1985, Biochemical pharmacology.

[12]  H. Yokoo,et al.  Effect of systemically administered caerulein on dopamine metabolism in rat brain , 1984, Brain Research.

[13]  J. Belleroche,et al.  The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat , 1984, Neuroscience Letters.

[14]  K. Kawasaki,et al.  Caerulein, a cholecystokinin-related peptide, depresses somatic function via the vagal afferent system. , 1983, Life sciences.

[15]  M. Starr.  Influence of peptides on 3H-dopamine release from superfused rat striatal slices , 1982, Neurochemistry International.

[16]  J. Morley,et al.  The effect of vagotomy on the satiety effects of neuropeptides and naloxone. , 1982, Life sciences.

[17]  G. P. Smith,et al.  Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. , 1981, Science.

[18]  R. Innis,et al.  Cholecystokinin receptors: presence and axonal flow in the rat vagus nerve. , 1981, Life sciences.

[19]  S. Paul,et al.  Vagotomy abolishes the inhibitory effects of cholecystokinin on rat exploratory behaviors , 1981 .

[20]  J. Christophe,et al.  Degradation of cholecystokinin-like peptides by a crude rat brain synaptosomal fraction: A study by high pressure liquid chromatography , 1981, Regulatory Peptides.

[21]  G. Zetler.  Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidol , 1981, Neuropharmacology.

[22]  B. Penke,et al.  Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice. , 1981, European journal of pharmacology.

[23]  T. Hökfelt,et al.  Evidence for coexistence of dopamine and CCK in meso-limbic neurones , 1980, Nature.

[24]  J. D. De Mey,et al.  Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Rehfeld,et al.  Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog. , 1978, The Journal of biological chemistry.

[26]  R. Yalow,et al.  Cholecystokinin and its COOH-terminal octapeptide in the pig brain. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. Dockray,et al.  Immunochemical evidence of cholecystokinin-like peptides in brain , 1976, Nature.

[28]  S. Lal,et al.  Cholecystokinin and schizophrenia. , 1986, Progress in brain research.

[29]  L. Pellegrino,et al.  stereotaxic atlas of the rat brain , 1967 .